Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • threads
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Safety
    • Nurse Well-Being
    • Drug Reference Sheets
    • ONS Congress
    • Specific Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Get Involved
    Stories View All
    View All
    patient looking at nurse with compassion
    Oncology Nurse-Patient Relationship
    How a Simple Conversation Led Me to Create Meaningful Change in Cancer Clinical Practice
    October 03, 2024
    Graduation cap with sun
    Decision-Making
    A Graduation Ceremony Against All Odds: Honoring a Student’s Final Wish  
    September 26, 2024
    cancer patient looking up at nurse
    Patient Quality of Life
    Tell Me What’s Happening
    September 12, 2024
    cozy hospital room with bed and computer
    Interprofessional Issues
    Novel, Interprofessional Approach Enhances Bed Assignments for Individuals on Antineoplastic Drugs in a Hospital Setting
    August 22, 2024
    hand touching futuristic screen that represents artificial intelligence
    Nurse Empowerment
    How AI Can Support Oncology Nurses’ Spirit of Inquiry
    August 15, 2024
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    ONS News

    Stay Tuned for the Launch of the New ONS Voice

    Happy New Year! With a new year comes new changes: earlier this month, ONS published the inaugural print issue of the ONS Voice, which is replacing your monthly ONS Connect. But we haven’t just given the news magazine a facelift: the ONS Voice is so much more than just “the new ONS Connect.”
    January 16, 2017
    Lung Cancer

    Seven New Substances Added to HHS Report on Carcinogens

    The U.S. Department of Health and Human Services (HHS) added seven new substances to the 14th release of its Report on Carcinogens in November 2016. This brings the total number of HHS-identified carcinogens to 248.
    December 27, 2016
    Research

    Oncomicrobiotics May Improve Efficacy of Chemotherapy

    The presence of certain intestinal bacteria types may improve the efficacy of alkylating chemotherapy agents such as cyclophosphamide, according to the results of a new study published in Immunity.
    December 20, 2016
    Lung Cancer

    Smoking Causes Higher Proportion of Cancer Deaths in Southern States

    Researchers looked at the burden of cigarette use across all U.S. states and found that the proportion of cancer deaths from smoking was highest in several Southern states, including Arkansas, Kentucky, Louisiana, Tennessee, and West Virginia.
    December 13, 2016
    feet on scale
    Clinical Practice

    Can You Identify and Manage Sarcopenic Obesity in Cancer Survivors?

    Sarcopenic obesity, a dual condition in which patients lose muscle mass but gain fat mass, can both be caused by and complicate cancer and its treatment.
    December 13, 2016
    Genetics & Genomics

    Gene Expression Helps Predict Benefit From Adjuvant Chemo for Breast Cancer

    Although nearly 60% of all patients with early-stage breast cancer are given adjuvant chemotherapy, only 2%–15% of them receive clinical benefit, according to research published in the 2016 American Society of Clinical Oncology Educational Book.
    October 18, 2016
    Breast Cancer

    Palbociclib Plus Letrozole Improves Survival in Advanced Breast Cancer

    A study presented at the 2016 ASCO annual meeting confirmed findings that led to the U.S. Food and Drug Administration approval of palbociclib in combination with letrozole for first-line treatment in women with estrogen receptor -positive, HER2-negative advanced breast cancer.
    October 11, 2016
    Breast Cancer

    Why More Women Are Choosing Bilateral Mastectomies

    In just seven years, the rates of women who received prophylactic bilateral mastectomies after a diagnosis of unilateral breast cancer skyrocketed—though many don't require bilateral mastectomy. So what’s causing the increase in unnecessary surgery?
    October 11, 2016
    Breast Cancer

    Neratinib May Be Effective for HER2-Positive Breast Cancer

    According to the results of a phase II, randomized study published in the New England Journal of Medicine, neratinib may effectively treat women with HER2-positive, hormone receptor-negative breast cancer.
    October 04, 2016
    Lung Cancer

    Weight Gain May Indicate Clinical Benefit in NSCLC

    Increasing weight during treatment may indicate early clinical benefit in patients with non-small cell lung cancer (NSCLC), according to the results of a study published in the Annals of Oncology.
    September 27, 2016
    Genetics & Genomics

    Thyroid Cancer Treatment’s Changing Landscape Brings New Hope to Patients

    Until 2011, no effective therapeutic options existed for advanced thyroid cancer. However, thanks to clinical studies that have improved the understanding of thyroid cancer’s molecular basis, four kinase inhibitors were approved by the U.S. Food and Drug Administration.
    September 27, 2016
    Cancer Treatments

    Inotuzumab Ozogamicin May Improve Survival in ALL

    Researchers have found that a monoclonal antibody called inotuzumab ozogamicin may help more patients with refractory B-cell acute lymphoblastic leukemia (ALL) proceed to stem cell transplantation. The findings were reported in the New England Journal of Medicine.
    September 20, 2016
    Immunotherapy

    MABp1 May Be Effective for Metastatic Colorectal Cancer

    A new immunotherapy drug, MABp1, is the first to target interleukin-1 alpha and may be effective in patients with metastatic colorectal cancer. The study results were presented at the World Congress of Gastrointestinal Cancer in Barcelona, Spain.
    September 13, 2016
    Immunotherapy

    An Oncology Nursing Overview of New Immune Checkpoint Inhibitors

    Immunotherapy has led to many new cancer treatments over the past several years and continues to offer increased options and better survival for patients. Oncology nurses need to have an understanding of how these therapies work and how to best manage patients’ side effects.
    September 13, 2016
    Cancer Screening

    Metastatic Prostate Cancer Increasing in United States

    The number of new U.S. cases of metastatic prostate cancer increased by 72% from 2004–2013, according to a new study published in Prostate Cancer and Prostatic Diseases.
    September 06, 2016
    Oncology Drug Research

    Maintenance Treatment May Prolong Progression-Free Survival in Ovarian Cancer

    Although response rates to chemotherapy are high, 90% of ovarian cancers will recur within two years. A new drug called niraparib is under investigation as maintenance treatment between cycles of platinum-based chemotherapy, and findings from phase III trials have shown promise.
    August 23, 2016
    Cancer Surgery

    Surgery Prolongs Survival for Patients With NSCLC

    Patients with late-stage non-small cell lung cancer who have surgery have better survival rates than those who don’t, according to the results of a recent study published in the Annals of Thoracic Surgery. The researchers also reported that despite the improved survival from surgery, fewer patients are receiving the treatment.
    August 23, 2016
    Cancer Treatments

    Poliovirus May Be Key to Treating Glioblastoma

    A phase I study has shown that a small group of patients with recurrent glioblastoma who received treatment with a modified form of poliovirus showed survival improvement over historical controls. The findings, which were not peer reviewed, were presented at the 2016 American Society of Clinical Oncology annual meeting.
    August 16, 2016
    Cancer Treatments

    Pembrolizumab Associated With Long-Term Survival in Advanced Melanoma

    A new study has shown that 40% of patients with previously treated advanced melanoma were alive at three years’ follow-up after initiating treatment with pembrolizumab. The results were presented at the 2016 American Society of Clinical Oncology annual meeting.
    August 09, 2016
    Comorbidities

    Aerobic and Resistance Exercise May Reduce Comorbidities in Cancer Survivors

    Although patients are living longer into survivorship, their comorbid burden is increasing. Studies have shown that survivors have increased rates of chronic disease, like type-2 diabetes and cardiovascular disease; and obesity compared to adults without cancer.
    August 09, 2016
    Lung Cancer

    Pretreatment Anemia Predicts Poor Survival From NSCLC

    Patients receiving stereotactic body radiation therapy for early-stage non-small cell lung cancer who have anemia at diagnosis may be more likely to have aggressive disease with poor survival and non-local progression, according to findings from a new study published in the Journal of Thoracic Oncology.
    August 02, 2016
    Oncology Drug Research

    New Class of Drugs Shows Promise in Treatment-Resistant Prostate Cancer

    Researchers in the United Kingdom are looking at a new class of drugs that attacks cancer indirectly through a network of signals, which may prevent or overcome drug resistance. The findings of the study were published in Cancer Research.
    July 26, 2016
    Adverse Events

    Sorafenib Adverse Events May Be More Common in Thyroid Cancer

    Researchers have found that patients receiving sorafenib for differential thyroid cancer are more likely to experience adverse events from the drug, compared to patients with renal or hepatocellular cancers. The findings were published in JAMA Oncology.
    July 19, 2016
    Prostate Cancer

    Prostate Radiotherapy May Increase Bladder Cancer Risk

    Patients with prostate cancer who undergo radiation treatment, especially brachytherapy, may be at increased risk of bladder cancer more than 10 years later, according to the results of a new study presented at the American Urological Association annual meeting.
    July 12, 2016
    Immunotherapy

    What Nurses Need to Know About Talimogene Laherparepvec for Advanced Melanoma

    A number of different oncolytic immunotherapies are in development for advanced melanoma, one of which is talimogene laherparepvec, a genetically modified recombinant herpes simplex virus type 1.
    July 12, 2016
    • First page « First
    • Previous page
    • …
    • Page 15
    • Page 16
    • Page 17
    • Page 18
    • Page 19
    • Page 20
    • Current page 21
    • Page 22
    • Page 23
    • Next page
    • Last page Last »

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    content['#byline_profile'].image_alt_text
    Elisa Becze BA, ELS, Editor
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Contact Us
  • Advertising
  • Newsroom
  • Conferences
  • RSS Feed
  • Sitemap
  • Legal Notices

    • Subscribe to ONS Voice Updates

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • threads
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2024 Oncology Nursing Society
    Back to Top ▲